Screening, diagnosis and evaluation

Ashish M. Kamat; Paul K. Hegarty

doi:10.2217/fmeb2013.13.22

Screening, diagnosis and evaluation

Ashish M. Kamat, Paul K. Hegarty

Urology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Current evidence suggests that whole population bladder cancer screening does not improve survival. Bladder cancer screening may be offered to patients at high risk for bladder cancer, consisting of annual urine cytology and dipstick urinalysis.

Original language	English (US)
Title of host publication	Advances in Bladder Cancer Management
Publisher	Future Medicine Ltd.
Pages	6-25
Number of pages	20
ISBN (Electronic)	9781780844237
ISBN (Print)	9781780844251
DOIs	https://doi.org/10.2217/fmeb2013.13.22
State	Published - Oct 1 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.2217/fmeb2013.13.22

Cite this

@inbook{eeb18b904721410db403caf8bba8163c,

title = "Screening, diagnosis and evaluation",

abstract = "Current evidence suggests that whole population bladder cancer screening does not improve survival. Bladder cancer screening may be offered to patients at high risk for bladder cancer, consisting of annual urine cytology and dipstick urinalysis.",

author = "Kamat, {Ashish M.} and Hegarty, {Paul K.}",

note = "Publisher Copyright: {\textcopyright}2015 Future Medicine Ltd.",

year = "2015",

month = oct,

day = "1",

doi = "10.2217/fmeb2013.13.22",

language = "English (US)",

isbn = "9781780844251",

pages = "6--25",

booktitle = "Advances in Bladder Cancer Management",

publisher = "Future Medicine Ltd.",

}

TY - CHAP

T1 - Screening, diagnosis and evaluation

AU - Kamat, Ashish M.

AU - Hegarty, Paul K.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Current evidence suggests that whole population bladder cancer screening does not improve survival. Bladder cancer screening may be offered to patients at high risk for bladder cancer, consisting of annual urine cytology and dipstick urinalysis.

AB - Current evidence suggests that whole population bladder cancer screening does not improve survival. Bladder cancer screening may be offered to patients at high risk for bladder cancer, consisting of annual urine cytology and dipstick urinalysis.

UR - http://www.scopus.com/inward/record.url?scp=84956826346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956826346&partnerID=8YFLogxK

U2 - 10.2217/fmeb2013.13.22

DO - 10.2217/fmeb2013.13.22

M3 - Chapter

AN - SCOPUS:84956826346

SN - 9781780844251

SP - 6

EP - 25

BT - Advances in Bladder Cancer Management

PB - Future Medicine Ltd.

ER -

Screening, diagnosis and evaluation

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this